Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1974 1
1975 23
1976 42
1977 50
1978 75
1979 84
1980 143
1981 151
1982 160
1983 193
1984 248
1985 259
1986 300
1987 272
1988 297
1989 330
1990 368
1991 306
1992 377
1993 489
1994 478
1995 464
1996 489
1997 510
1998 582
1999 551
2000 660
2001 655
2002 607
2003 664
2004 679
2005 708
2006 685
2007 746
2008 657
2009 645
2010 695
2011 715
2012 659
2013 747
2014 709
2015 679
2016 609
2017 564
2018 534
2019 273
2020 16
Text availability
Article attribute
Article type
Publication date

Search Results

18,887 results
Results by year
Filters applied: . Clear all
Page 1
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.
Francis PA, Pagani O, Fleming GF, Walley BA, Colleoni M, Láng I, Gómez HL, Tondini C, Ciruelos E, Burstein HJ, Bonnefoi HR, Bellet M, Martino S, Geyer CE Jr, Goetz MP, Stearns V, Pinotti G, Puglisi F, Spazzapan S, Climent MA, Pavesi L, Ruhstaller T, Davidson NE, Coleman R, Debled M, Buchholz S, Ingle JN, Winer EP, Maibach R, Rabaglio-Poretti M, Ruepp B, Di Leo A, Coates AS, Gelber RD, Goldhirsch A, Regan MM; SOFT and TEXT Investigators and the International Breast Cancer Study Group. Francis PA, et al. N Engl J Med. 2018 Jul 12;379(2):122-137. doi: 10.1056/NEJMoa1803164. Epub 2018 Jun 4. N Engl J Med. 2018. PMID: 29863451 Free PMC article. Clinical Trial.
Association of tamoxifen resistance and lipid reprogramming in breast cancer.
Hultsch S, Kankainen M, Paavolainen L, Kovanen RM, Ikonen E, Kangaspeska S, Pietiäinen V, Kallioniemi O. Hultsch S, et al. BMC Cancer. 2018 Aug 24;18(1):850. doi: 10.1186/s12885-018-4757-z. BMC Cancer. 2018. PMID: 30143015 Free PMC article.
Tamoxifen and CYP2D6: A Controversy in Pharmacogenetics.
Cronin-Fenton DP, Damkier P. Cronin-Fenton DP, et al. Adv Pharmacol. 2018;83:65-91. doi: 10.1016/bs.apha.2018.03.001. Epub 2018 May 7. Adv Pharmacol. 2018. PMID: 29801584 Review.
Clinical pharmacokinetics and pharmacogenetics of tamoxifen and endoxifen.
Sanchez-Spitman AB, Swen JJ, Dezentje VO, Moes DJAR, Gelderblom H, Guchelaar HJ. Sanchez-Spitman AB, et al. Expert Rev Clin Pharmacol. 2019 Jun;12(6):523-536. doi: 10.1080/17512433.2019.1610390. Epub 2019 Apr 30. Expert Rev Clin Pharmacol. 2019. PMID: 31008668 Review.
Breast Cancer in Men.
Giordano SH. Giordano SH. N Engl J Med. 2018 Jun 14;378(24):2311-2320. doi: 10.1056/NEJMra1707939. N Engl J Med. 2018. PMID: 29897847 Review. No abstract available.
Tamoxifen therapy in a murine model of myotubular myopathy.
Maani N, Sabha N, Rezai K, Ramani A, Groom L, Eltayeb N, Mavandadnejad F, Pang A, Russo G, Brudno M, Haucke V, Dirksen RT, Dowling JJ. Maani N, et al. Nat Commun. 2018 Nov 19;9(1):4849. doi: 10.1038/s41467-018-07057-5. Nat Commun. 2018. PMID: 30451841 Free PMC article.
Tamoxifen Pharmacogenetics and Metabolism: Results From the Prospective CYPTAM Study.
Sanchez-Spitman A, Dezentjé V, Swen J, Moes DJAR, Böhringer S, Batman E, van Druten E, Smorenburg C, van Bochove A, Zeillemaker A, Jongen L, Los M, Neven P, Gelderblom H, Guchelaar HJ. Sanchez-Spitman A, et al. J Clin Oncol. 2019 Mar 10;37(8):636-646. doi: 10.1200/JCO.18.00307. Epub 2019 Jan 24. J Clin Oncol. 2019. PMID: 30676859 Clinical Trial.
18,887 results
Jump to page
Feedback